Danish pharmaceutical company Novo Nordisk’s CEO said that the company is prepared for a potential tariff war launched by Trump as tensions rise between Copenhagen and Washington. Novo Nordisk CEO Lars Fruergaard Jorgensen said in an interview on Wednesday that the company has more than 10,000 employees in the United States, and most of the supply chain in the U.S. will “largely” meet local needs, and “Benchmark” scenarios can be handled.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Danimarka ve ABD arasındaki gerginlik artıyor, Novo Nordisk CEO'su Trump'ın gümrük vergisi tehdidine karşı hazır olduğunu belirtti
Danish pharmaceutical company Novo Nordisk’s CEO said that the company is prepared for a potential tariff war launched by Trump as tensions rise between Copenhagen and Washington. Novo Nordisk CEO Lars Fruergaard Jorgensen said in an interview on Wednesday that the company has more than 10,000 employees in the United States, and most of the supply chain in the U.S. will “largely” meet local needs, and “Benchmark” scenarios can be handled.